Market Cap

Novo Nordisk Market Capitalization:

Novo Nordisk A/S

kr.4.320 Trillion

DKK as of July 1, 2024

US$622.07 Billion

business Novo Nordisk Company Profile

Novo Nordisk Main Stock Listing

OMXC: NOVO.B

Market capitalization history of Novo Nordisk

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Top Competitors by Market Capitalization

Industry: Biotechnology
Company Market Cap (USD)
Vertex Pharmaceuticals Incorporated $113.24 B
CSL Limited $95.75 B
Regeneron Pharmaceuticals, Inc. $76.33 B
Marinomed Biotech AG $56.13 B
Samsung Biologics Co.,Ltd. $49.14 B
Sector: Healthcare
Company Market Cap (USD)
Lilly $689.42 B
UnitedHealth Group $487.54 B
Johnson & Johnson $353.05 B
AbbVie $301.60 B
Merck $244.44 B

Yearly evolution of Novo Nordisk market cap

Date Market Cap YoY Change
Jan. 1, 2024 kr.3.117 T 47.00%
Jan. 1, 2023 kr.2.120 T 48.04%
Jan. 1, 2022 kr.1.432 T 54.23%
Jan. 1, 2021 kr.928.71 B 3.13%
Jan. 1, 2020 kr.900.55 B 35.60%
Jan. 1, 2019 kr.664.11 B -8.76%
Jan. 1, 2018 kr.727.86 B 34.76%
Jan. 1, 2017 kr.540.11 B -34.88%
Jan. 1, 2016 kr.829.38 B 28.56%
Jan. 1, 2015 kr.645.12 B 34.93%
Jan. 1, 2014 kr.478.11 B 8.31%
Jan. 1, 2013 kr.441.43 B 50.45%
Jan. 1, 2012 kr.293.42 B 9.54%
Jan. 1, 2011 kr.267.87 B 67.39%
Jan. 1, 2010 kr.160.02 B 17.28%
Jan. 1, 2009 kr.136.45 B 0.16%
Jan. 1, 2008 kr.136.23 B 26.57%
Jan. 1, 2007 kr.107.63 B 43.31%
Jan. 1, 2006 kr.75.10 B 13.16%
Jan. 1, 2005 kr.66.37 B 27.46%
Jan. 1, 2004 kr.52.07 B 25.86%
Jan. 1, 2003 kr.41.37 B -38.67%
Jan. 1, 2002 kr.67.46 B

Market capitalization is calculated from the opening stock price at the beginning of each year.

Top 1-year algo backtest: +327.04%

$10,000 in March 2024 would now be $42,704 by following this algorithm daily at market close.

Use AI to boost your investing & swing trading, now!

Try Disfold DeepFinance FREE

Company Description

Novo Nordisk is a global healthcare company involved in the research, development, manufacture, and marketing of pharmaceutical products. It operates through two segments: Diabetes and Obesity care, providing products for insulins, GLP-1, oral antidiabetic products, obesity, and other chronic diseases; and Biopharm, offering products for haemophilia, growth disorders, and hormone replacement therapy.

business Novo Nordisk Company Profile

Novo Nordisk Categories

Denmark languages Healthcare languages Biotechnology
Denmark Healthcare Denmark Biotechnology

Stocks & Indices

Novo Nordisk A/S has the following listings and related stock indices.


Stock: OMXC: NOVO.B

Stock: FSX: NOVC

Stock: XETR: NOVC

Stock: XETR: NOVA

Stock: FSX: NOVA

Stock: BMV: NVON

Stock: NYSE: NVO

Stock: Bovespa: N1VO34

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.